QT-prolonging medications: prevalence of use and associated risks in CKD.
- DOI
- 10.1093/ndt/gfaf196
- Published
- 2026 Mar 31
- Container
- Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/ndt/gfaf196,
title = {QT-prolonging medications: prevalence of use and associated risks in CKD.},
author = {Liabeuf S and Berdougo-Tritz J and Augey L and Laville SM and Mbarek A and Deray G and Massy ZA and Jadoul M},
year = {2026},
journal = {Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association},
doi = {10.1093/ndt/gfaf196},
url = {https://doi.org/10.1093/ndt/gfaf196}
}RIS
TY - JOUR TI - QT-prolonging medications: prevalence of use and associated risks in CKD. AU - Liabeuf S AU - Berdougo-Tritz J AU - Augey L AU - Laville SM AU - Mbarek A AU - Deray G AU - Massy ZA AU - Jadoul M PY - 2026 JO - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association DO - 10.1093/ndt/gfaf196 UR - https://doi.org/10.1093/ndt/gfaf196 ER -
APA
S, L., J, B., L, A., SM, L., A, M., G, D., ZA, M., & M, J. (2026). QT-prolonging medications: prevalence of use and associated risks in CKD.. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. https://doi.org/10.1093/ndt/gfaf196
Source records
- pubmed · retrieved 2026-09-27T14:31:17.060Z